Dairy Products, 2003 Summary

机译：乳制品，2003年总结

获取原文

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Total cheese production, excluding cottage cheeses, was 8.60 billion pounds, 0.6 percent above 2002 production. Wisconsin was the leading State with 26.5 percent of the production.

著录项

作者

展开▼
作者单位

展开▼
年度 2004
页码 p.1-84
总页数 84
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Agricultural economics; Dairy products; United States; Production; Cheeses; Butter; Milk; Prices; Tables(Data); Statistical data;

机译：农业经济学;乳制品;美国;生产;奶酪;黄油;牛奶;价格;表（数据）;统计数据;

相似文献

外文文献
中文文献
专利

1. Using the NRC chemical summary and biological approaches to predict energy values of new co-product from bio-ethanol production for dairy cows. [J] . Nuez-Ortin W. G., Yu PeiQiang Animal Feed Science and Technology . 2011,第3a4期

机译：使用NRC化学摘要和生物学方法来预测奶牛生物乙醇生产中新副产品的能量值。
2. Benefits of dairy product consumption on blood pressure in humans: a summary of the biomedical literature. [J] . Miller GD, DiRienzo DD, Reusser ME, Journal of the American College of Nutrition . 2000,第2Suppla期

机译：食用乳制品对人类血压的好处：生物医学文献的摘要。
3. Benefits of dairy product consumption on blood pressure in humans: a summary of the biomedical literature. [J] . Miller GD, DiRienzo DD, Reusser ME, Journal of the American College of Nutrition . 2000,第2期

机译：食用乳制品对人类血压的好处：生物医学文献的摘要。
4. The 2003 Canadian Asphalt Exchange Program (CAEP) 2003 Summary [C] . Magdy Beshara Canadian Technical Asphalt Association(CTAA) Annual Conference; 200411; Montreal(CA) . 2004

机译：2003年加拿大沥青交换计划（CAEP）2003年摘要
5. Synergistic Effect of High Intensity Ultrasound, Antimicrobial Compounds, and UV-A Light on Microbial Quality of Dairy Products [D] . Hales, Bryce Rodney. 2021

机译：高强度超声，抗微生物化合物和紫外线 - 乳制品微生物品质的协同效应
6. Introduction and Executive Summary of the Supplement Role of Milk and Dairy Products in Health and Prevention of Noncommunicable Chronic Diseases: A Series of Systematic Reviews [O] . Ángel Gil, Rosa M Ortega 2019

机译：乳制品和乳制品在健康和非传染性慢性病预防中的作用及其补充的介绍和执行摘要：一系列系统评价
7. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)44The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur.55This document was approved by the American College of Cardiology Foundation Board of Trustees in July, 2003, the American Heart Association Science Advisory and Coordinating Committee in July, 2003, and the American Society of Nuclear Cardiology Board of Directors in July, 2003.66When citing this document, the American College of Cardiology Foundation, the American Heart Association, and the American Society of Nuclear Cardiology request that the following citation format be used: Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, Kennedy JW, Lorell BH, Messer JV, O’Gara PT, Russell RO Jr, St. John Sutton MG, Udelson JE, Verani MS, Williams KA. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318–33.77(J Am Coll Cardiol 2003;42:1318–33)88©2003 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Klocke Francis J, Baird Michael G, Lorell Beverly H, 2003

机译：ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / ASNC委员会，对1995年临床使用指南进行修订ACC / AHA实践指导小组）竭尽全力避免由于写作小组成员的外部关系或个人利益而引起的任何实际或潜在的利益冲突。具体来说，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审查，在第一次会议上向书面小组的所有成员口头报告，并在发生变化时进行更新。55本文件于2003年7月获得美国心脏病学会基金会董事会的批准。 2003年7月，美国心脏协会科学咨询与协调委员会，2003年7月，美国核心脏病学会理事会。66引用该文件时，美国心脏病学会基金会，美国心脏协会和美国核学会心脏病学要求使用以下引用格式：Klocke FJ，Baird MG，Bateman TM，Berman DS，Carabello BA，Cerqueira MD，DeMaria AN，Kennedy JW，Lorell BH，Messer JV，O'Gara PT，Russell RO Jr，St John Sutton MG，Udelson JE，Verani MS，Williams KA。 ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要：美国心脏病学会/美国心脏协会实践小组工作指南（ACC / AHA / ASNC委员会，修订1995年临床指南）的报告使用放射性核素成像）。 J Am Coll Cardiol 2003; 42：1318–33.77（J Am Coll Cardiol 2003; 42：1318–33）88©2003美国心脏病学会基金会和美国心脏协会版权所有。
8. New Zealand: Dairy and Products. New Zealand Dairy and Products 2007 Annual Report. GAIN Report Number NZ7030 [R] . Lee-Jones, D. E. 2007

机译：新西兰：乳制品和产品。新西兰乳制品和产品2007年度报告。 GaIN报告编号NZ7030

Dairy Products, 2003 Summary

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅